J
Joachim Denner
Researcher at Robert Koch Institute
Publications - 233
Citations - 7776
Joachim Denner is an academic researcher from Robert Koch Institute. The author has contributed to research in topics: Xenotransplantation & Endogenous retrovirus. The author has an hindex of 46, co-authored 212 publications receiving 6655 citations. Previous affiliations of Joachim Denner include Ludwig Maximilian University of Munich & Free University of Berlin.
Papers
More filters
Journal ArticleDOI
Expression of human endogenous retrovirus K in melanomas and melanoma cell lines.
TL;DR: Viral proteins were shown to be expressed in primary melanomas, metastases, and melanoma cell lines by immunohistochemistry, immunofluorescence, and Western blot analyses using specific antisera and for the first time, antibodies against HERV-K were found in melanoma patients.
Journal ArticleDOI
Microbiological safety of the first clinical pig islet xenotransplantation trial in New Zealand.
TL;DR: The first clinical trial of (alginate‐encapsulated) porcine islet cell transplantation in New Zealand, which was approved by the New Zealand Government as an open‐label phase I/IIa safety/efficacy trial, offers the possibility to analyze microbiological safety in a prospective clinical study.
Journal ArticleDOI
Clinical extracorporeal hybrid liver support – phase I study with primary porcine liver cells
Igor M. Sauer,D. Kardassis,K. Zeillinger,Andreas Pascher,A. Gruenwald,Gesine Pless,Markus Irgang,M. Kraemer,Gero Puhl,J. Frank,Andrea R. Müller,Th. Steinmüller,Joachim Denner,Peter Neuhaus,J. C. Gerlach,J. C. Gerlach +15 more
TL;DR: Evaluating the feasibility and safety of a hybrid liver support system with extracorporeal plasma separation and bioreactor perfusion in patients with acute liver failure who had already fulfilled the criteria for high urgency liver transplantation (LTx) found it safe and well‐tolerated.
Journal ArticleDOI
Infection Barriers to Successful Xenotransplantation Focusing on Porcine Endogenous Retroviruses
Joachim Denner,Ralf R. Tönjes +1 more
TL;DR: Highly sensitive and specific methods have been developed to analyze the PERV status of donor pigs and to monitor recipients for PERV infection, including selection of PERV-C-negative, low-producer pigs, generation of an effective vaccine, selection of effective antiretrovirals, and generation of animals transgenic for a PERv-specific short hairpin RNA inhibiting PERV expression by RNA interference.
Journal ArticleDOI
Lack of evidence for xenotropic murine leukemia virus-related virus(XMRV) in German prostate cancer patients
Oliver Hohn,Hans Krause,Pia Barbarotto,Lars Niederstadt,Nadine Beimforde,Nadine Beimforde,Joachim Denner,Kurt Miller,Reinhard Kurth,Norbert Bannert +9 more
TL;DR: The results indicate a much lower prevalence (or even complete absence) of XMRV in prostate tumor patients in Germany, and one possible reason for this could be a geographically restricted incidence of X MRV infections.